BICD2 anticorps (AA 300-350)

N° du produit ABIN6990934

Détail du produit anti-BICD2 anticorps

Antigène: BICD2 (Bicaudal D Homolog 2 (BICD2))

Épitope: AA 300-350

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BICD2 est non-conjugé

Application: Western Blotting (WB), ELISA

Specificité: This BICD2 antibody will not cross-react with BICD1.

Purification: BICD2 Antibody is affinity chromatography purified via peptide column.

Immunogène: BICD2 antibody was raised against a 14 amino acid synthetic peptide from near the center of human BICD2. The immunogen is located within amino acids 300 - 350 of BICD2.

Isotype: IgG

Information d'application

Indications d'application: BICD2 antibody can be used for detection of BICD2 by Western blot at 1 - 2 μ,g/mL.

Antibody validated: Western Blot in human samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: BICD2 Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: BICD2 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur BICD2

Antigène: BICD2 (Bicaudal D Homolog 2 (BICD2))

Autre désignation: BICD2 (BICD2 Produits)

Sujet: BICD2 Antibody: BICD2 is the second human homolog discovered to the Drosophila Bicaudal-D protein that forms part of the cytoskeleton and mediates the correct sorting of mRNAs for oocyte- and axis-determining factors during oogenesis. Similar to the highly homologous protein BICD1, BICD2 can bind to dynein-dynactin complex, primarily through the dynamitin subunit of dynactin. The C-terminus of BICD2 targets the protein to the Golgi complex while the N-terminal domain of BICD2 co-immunoprecipitates with cytoplasmic dynein, suggesting BICD2 plays a role in the dynein-dynactin interaction on the surface of membranous organelles. Mice engineered to overexpress the BICD2 amino terminal domain in neurons developed amyotrophic lateral sclerosis (ALS)-like features such as Golgi fragmentation, neurofilament swelling in proximal axons, etc., suggesting that impaired dynein/dynactin function may explain some of the pathological features observed in ALS patients.

Poids moléculaire: Predicted: 94 kDa

Observed: 100 kDa

ID gène: 23299

UniProt: Q8TD16

Pathways: Maintenance of Protein Location